Myocardial viability imaging using Gd-DTPA: physiological modeling of infarcted myocardium, and impact on injection strategy and imaging time.
Results of simulations are shown which illustrate how the concentration-time curves of an extravascular extracellular (EVEC) contrast agent, such as Gd-DTPA, vary in myocardial tissue. The simulations show that the variable permeability of dead myocytes within a recent myocardial infarction will significantly alter delayed enhancement patterns following a bolus injection, invariably reducing the sensitivity of this technique for the detection of permanently damaged tissue. It is further predicted that if the bolus injection is followed by a suitably selected constant infusion, the infarct size and infarct volume of distribution may be more accurately determined, even though the degree of enhancement of an infarcted region (with normal flow) above normal tissue is slightly higher for the bolus technique within the first 30 min following the injection. The degree of enhancement of an infarcted region (with normal flow) above normal tissue was comparable between the two techniques at the point in the constant infusion at which the volume of contrast injected was the same as in the bolus case, i.e., at approximately 30 min after the bolus injection. The constant infusion approach became superior thereafter as overall tissue concentrations became greater in both normal and infarcted tissue, and these concentrations remained more stable with the constant infusion approach. Preliminary experimental results in a canine model of infarction/reperfusion illustrated a delayed wash-in of contrast agent in infarcted tissue, which may be explained by a physiological model in which dead myocytes in infarcted myocardium have non-infinite permeability.
Moran
G R
GR
Department of Nuclear Medicine and Magnetic Resonance, Lawson Health Research Institute, St Joseph's Health Care, London, Canada. marang@mcmaster.ca
Thornhill
R E
RE
Sykes
J
J
Prato
F S
FS
D000818:Animals; D003287:Contrast Media / Q000008:administration & dosage / Q000378:metabolism*; D004285:Dogs; D019786:Gadolinium DTPA / Q000008:administration & dosage / Q000378:metabolism; D008279:Magnetic Resonance Imaging; D008955:Models, Cardiovascular; D008991:Monitoring, Physiologic; D009203:Myocardial Infarction / Q000175:diagnosis / Q000378:metabolism* / Q000503:physiopathology; D009206:Myocardium / Q000378:metabolism*; D010865:Pilot Projects
D003287:Contrast Media; D019786:Gadolinium DTPA